A Common CHAT Gene Mutation of Congenital Myasthenic Syndrome Found in Kadazandusun Children

Abstract

Congenital myasthenic syndrome (CMS) is an uncommon inherited neuromuscular junction disease. The clinical presentation of this disorder is diverse. Typically patients with this disorder present with early-onset swallowing difficulty and apnea in infancy, fluctuating ocular palsies and fatigable proximal muscle weakness during childhood, and late-onset form involving progressive weakness in adulthood. Difficulty in performing neurophysiology studies in children and the absence of a pathognomonic investigation marker increase the challenges in diagnosis of this disorder. The emergence of next-generation sequencing technology has circumvented these challenges somewhat, and has contributed to the discovery of novel mutations. We present here diagnostic odyssey of three CMS patients from two unrelated Kadazandusun kinships and their follow-up treatment. A rare homozygous mutation c.916G > C (p.Val306Leu) in CHAT gene was found in two siblings born of a consanguineous marriage. Third patient had compound heterozygous mutations c.406G > A (p.Val136Met) and c.916G > C (p.Val306Leu) in CHAT gene. We postulate that p.Val306Leu may be a founder mutation in the Kadazandusuns, an indigenous ethnic minority of Borneo Island.

Keywords

congenital myasthenic syndrome - CHAT - Kadazandusun - apnea

Publication History

Received: 07 November 2021

Accepted: 09 March 2022

Article published online:
15 September 2022

• References

• 1 Abicht A, Muller JS, Lochmuller H. Congenital Myasthenic Syndrome. May 9 2003 (updated 2016 July 14). In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. eds. GeneReviews. Seattle, WA: University of Washington, Seattle; 1993–2020 (updated 2016 July 14). Available at: http://www.ncbi.nlm.nih.gov/books/NBK1168/
• 2 Arican P, Gencpinar P, Cavusoglu D, Olgac Dundar N. Clinical and genetic features of congenital myasthenic syndromes due to CHAT mutations: case report and literature review. Neuropediatrics 2018; 49 (04) 283-288
• 3 Finsterer J. Congenital myasthenic syndromes. Orphanet J Rare Dis 2019; 14 (01) 57
• 4 Zhang Y, Cheng X, Luo C. et al. Congenital myasthenic syndrome caused by a novel hemizygous CHAT mutation. Front Pediatr 2020; 8: 185
• 5 Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol 2015; 14 (04) 420-434
• 6 Kinali M, Beeson D, Pitt MC. et al. Congenital myasthenic syndromes in childhood: diagnostic and management challenges. J Neuroimmunol 2008; 201-202: 6-12
• 7 Vanhaesebrouck AE, Beeson D. The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies. Curr Opin Neurol 2019; 32 (05) 696-703
• 8 Nicolau S, Milone M. The electrophysiology of presynaptic congenital myasthenic syndromes with and without facilitation: from electrodiagnostic findings to molecular mechanisms. Front Neurol 2019; 10: 257
• 9 Abbott RJ, Holden D, Currie S. False positive anti-acetylcholine receptor antibodies in motorneurone disease. Lancet 1986; 1 (8486): 906-907
• 10 Rajput R, Sachdev A, Din N, Damato EM, Murray A. False positive acetylcholine receptor antibodies in a case of unilateral chronic progressive external ophthalmoplegia: case report and review of literature. Orbit 2018; 37 (05) 385-388
• 11 Maselli RA, Chen D, Mo D, Bowe C, Fenton G, Wollmann RL. Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetylcholine resynthesis. Muscle Nerve 2003; 27 (02) 180-187
• 12 Arredondo J, Lara M, Gospe Jr SM. et al. Choline acetyltransferase mutations causing congenital myasthenic syndrome: molecular findings and genotype-phenotype correlations. Hum Mutat 2015; 36 (09) 881-893
• 13 Tan JS, Ambang T, Ahmad-Annuar A, Rajahram GS, Wong KT, Goh KJ. Congenital myasthenic syndrome due to novel CHAT mutations in an ethnic kadazandusun family. Muscle Nerve 2016; 53 (05) 822-826